Fractyl Health (GUTS) Accumulated Expenses (2023 - 2025)
Fractyl Health (GUTS) reported Accumulated Expenses of $4.4 million for Q3 2025, up 2.24% year-on-year from $4.3 million in Q3 2024, and up 42.62% quarter-over-quarter from $3.1 million in Q2 2025.
Fractyl Health (GUTS) has 3 years of Accumulated Expenses data on file, last reported at $4.4 million in Q3 2025.
- For the quarter ending Q3 2025, Accumulated Expenses rose 2.24% year-over-year to $4.4 million; the trailing twelve-month figure through Sep 2025 stood at $4.4 million (up 2.24% YoY), and the FY2024 full-year result was $4.2 million, up 19.54% from the prior year.
- Accumulated Expenses for Q3 2025 stood at $4.4 million, up from $3.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $5.0 million in Q1 2024 and bottomed at $2.9 million in Q1 2025.
- A 3-year average of $3.8 million and a median of $3.8 million in 2023 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses increased 19.54% in 2024 and tumbled 42.05% in 2025, its largest moves.
- Tracing GUTS's Accumulated Expenses over 3 years: stood at $3.5 million in 2023, then advanced by 19.54% to $4.2 million in 2024, then climbed by 4.78% to $4.4 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $4.4 million, $3.1 million, and $2.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Sep 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 3.50 Mn |